Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
[NFS-01-2]Developing a new HDO technology using morpholino oligomer to regulate gene expression
Tetsuya Nagata1,2(1.NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan, 2.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan)
2022-Current
Professor, NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University
2018-2022
Research Associate Professor, Department of Neurology, Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2014-2018
Research Senior Assistant Professor, Department of Neurology, Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2009-2014
Section chief, Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry
2008
Assistant Professor, Department of Neurology, Okayama University School of Medicine
2005-2008
Postdoctoral fellow, Department of Neurology/Center for Motor Neuron Biology and Disease, Columbia University
2003-2005
Assistant Professor, Department of Neurology, Okayama University School of Medicine
1999
Graduated from Tohoku University Graduate School
1994
Graduated from Tohoku University School of Medicine
Password required to view
Abstract password authentication.
You can find the password on page 15 of the program book.
You can find the password on page 15 of the program book.